Clinical Trials on Chronic Obstructive Pulmonary Disease in United States
Total 17048 results
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Cardiff UniversityGlaxoSmithKline; Cardiff Metropolitan UniversityCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
University of LeicesterRecruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Minnesota HealthSolutionsMayo ClinicCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Northwestern UniversityDepartment of Health and Human ServicesCompleted
-
Deep BreezeCompletedChronic Obstructive Pulmonary Disease | AsthmaUnited States
-
Almirall, S.A.Forest LaboratoriesCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
ChimerixTerminatedChronic Obstructive Pulmonary DiseaseUnited States, Canada, Belgium, Poland, Germany
-
AstraZenecaAmgenCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, France, United Kingdom, Korea, Republic of, Germany, Israel, Spain, Netherlands
-
University Hospital Southampton NHS Foundation...GlaxoSmithKlineCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
DeyCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
St George's, University of LondonBritish Lung Foundation; Medical Research CouncilCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Northumbria Healthcare NHS Foundation TrustNewcastle-upon-Tyne Hospitals NHS TrustRecruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Imperial College LondonCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, Germany, South Africa, Spain, United Kingdom, Italy, Argentina, Bulgaria, Mexico, Turkey, Poland, Netherlands
-
Xention LtdArio Pharma LtdCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Royal Free and University College Medical SchoolBoehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, United States, Denmark, Italy, Germany, Hungary, Netherlands, Spain, United Kingdom, Belgium, Argentina, Bulgaria, Canada, India, Japan, Vietnam, Brazil, Malaysia, Thailand, France, Mexico, Greece, Poland, Korea, Republic of, Peru, Chil... and more
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease | Interstitial Lung DiseaseUnited States
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease | COPD | Chronic BronchitisUnited States
-
Prosonix LimitedCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Research in Real-Life LtdTeva Branded Pharmaceutical Products R&D, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
South Eastern Health and Social Care TrustCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom, Netherlands
-
Hull University Teaching Hospitals NHS TrustCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUkraine, Argentina, Chile, Poland, Russian Federation, Turkey, United States, Australia, Canada, Germany
-
Dartmouth-Hitchcock Medical CenterCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; National Institute for Health Research: CLAHRC YH; The... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Loughborough UniversityCompleted
-
University of California, San FranciscoTerminatedPulmonary Disease, Chronic Obstructive | Pulmonary Diseases, ObstructiveUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Centers for Medicare and Medicaid ServicesCompleted
-
VA Office of Research and DevelopmentCompletedPulmonary Hypertension | Chronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
Sunovion Respiratory Development Inc.Completed
-
MedImmune LLCCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Czech Republic, Poland, United Kingdom, Philippines, Latvia, Lithuania, Ukraine, Hungary
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
Queen's University, BelfastCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Respivert LtdCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnHead and Neck Cancer | Chronic Obstructive Pulmonary Disease | Lung CancerUnited States
-
Patrick MurphyPhilips RespironicsCompletedOSA | COPDUnited Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Chiesi Farmaceutici S.p.A.Chiesi USA, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Czech Republic, Germany, Poland, Romania, South Africa
-
Queen Mary University of LondonGlaxoSmithKline; British Lung FoundationCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Korea, Republic of, Argentina, Canada, India, Bulgaria, Poland
-
Teesside UniversityRecruitingChronic Obstructive Pulmonary Disease | Healthy VolunteersUnited Kingdom
-
Novartis PharmaceuticalsCompleted
-
University of SouthamptonGlaxoSmithKlineCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom